Evidence map›Paper›PMID 38380019›Full record

ArticleHeliyon2024

Association of long COVID with health-related Quality of Life and Social Participation in Germany: Finding from an online-based cross-sectional survey.

Dominik Schröder, Stephanie Heinemann, Gloria Heesen, Eva Hummers, Tim Schmachtenberg, Alexandra Dopfer-Jablonka, Kai Vahldiek, Frank Klawonn, Sandra Klawitter, Sandra Steffens and 3 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Dominik SchröderDepartment of General Practice, University Medical Center, Göttingen, Germany.
Stephanie HeinemannDepartment of General Practice, University Medical Center, Göttingen, Germany.
Gloria HeesenDepartment of General Practice, University Medical Center, Göttingen, Germany.
Eva HummersDepartment of General Practice, University Medical Center, Göttingen, Germany.
Tim SchmachtenbergDepartment of General Practice, University Medical Center, Göttingen, Germany.
Alexandra Dopfer-JablonkaDepartment of Rheumatology and Immunology, Hannover Medical School, Germany.
Kai VahldiekDepartment of Computer Science, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany.
Frank KlawonnDepartment of Computer Science, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany.
Sandra KlawitterDepartment of Computer Science, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany.
Sandra SteffensDepartment of Rheumatology and Immunology, Hannover Medical School, Germany.
Marie MikuteitDepartment of Rheumatology and Immunology, Hannover Medical School, Germany.
Jacqueline NiewolikDepartment of Rheumatology and Immunology, Hannover Medical School, Germany.
Frank MüllerDepartment of General Practice, University Medical Center, Göttingen, Germany.
Medizinische Hochschule Hannover · DEUniversitätsmedizin Göttingen · DEOstfalia University of Applied Sciences · DEGrand Rapids Community College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aims to examine the health-related Quality of Life (hrQoL) and social participation in participants with Long COVID compared to participants without symptoms after COVID-19 and participants with no prior SARS-CoV-2 infection. Methods: A cross-sectional online survey was conducted in Germany. The non-random sample consists of participants 18 years or older. Participants were divided in three groups: Lg COVID with a prior SARS-CoV-2 infection and new or persistent symptoms 28 days after infection, ExCOVID with a prior SARS-CoV-2 infection and without new or persistent symptoms after 28 days, and NoCOVID when participants had no prior SARS-CoV-2 infection. EQ-5D-3L was used as hrQoL measure and the Index for the Assessment of Health Impairments (IMET) to reflect social participation. Descriptive and inferential statistics were performed. Results: A total of 3188 participants were included in the analysis (1421 Lg COVID, 260 ExCOVID, 1507 NoCOVID). Lg COVID was associated with the lowest EQ-5D-3L index values (p < 0.001), Visual Analogue Scale (VAS) scores (p < 0.001), and IMET (p < 0.001) scores followed by NoCOVID and ExCOVID. After adjusting for sociodemographic and medical conditions in a multivariable model Long COVID was still associated with lower hrQoL compared to NoCOVID (p < 0.001). About 10% of Lg COVID participants showed no health impairments in all EQ-5D dimensions while 51.1% of NoCOVID and 60% of ExCOVID participants showed no health impairments. Conclusion: This study highlights the impairments of persons with Long COVID on hrQoL and social participation compared to individuals without Long COVID in Germany. Trial registration: German Clinical Trial Registry, DRKS00026007.

Indexed as

COVID-19Patient reported outcome measuresPost-acute COVID-19 syndromeQuality of lifeSocial participation

Identifiers

PMID38380019
PMCPMC10877341
OpenAlexW4391691946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.